Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from GMO Financial Gate, Inc. ( (JP:4051) ) is now available.
GMO Financial Gate reported that revenue and profits for the first six months of the fiscal year ending September 30, 2026 significantly exceeded its prior forecast, with revenue up 21.7% and profit attributable to owners of parent rising 14.9%. The upside was driven by the earlier-than-planned delivery of a large drug store project, successful promotional efforts that accelerated merchant acquisition among SMEs, and steady expansion of recurring-model revenue alongside higher transaction volume and GMV, while the company left its full-year earnings and dividend forecasts unchanged, signaling management’s confidence in the existing outlook despite the strong interim performance.
The most recent analyst rating on (JP:4051) stock is a Buy with a Yen8300.00 price target. To see the full list of analyst forecasts on GMO Financial Gate, Inc. stock, see the JP:4051 Stock Forecast page.
More about GMO Financial Gate, Inc.
GMO Financial Gate, Inc. is a Japan-based payments company listed on the TSE Prime Market that provides cashless settlement infrastructure and related services. The company focuses on merchants such as drug stores and small and medium-sized enterprises, generating growing recurring revenue tied to transaction volumes and Gross Merchandise Value in the domestic cashless payments market.
Average Trading Volume: 37,931
Technical Sentiment Signal: Buy
Current Market Cap: Yen46.7B
For a thorough assessment of 4051 stock, go to TipRanks’ Stock Analysis page.